Join our cause and support us. Help us to continue supporting the patient’s community of rare lymphatic diseases in Europe. Today and in the future.

El Grupo de Trabajo de Anomalías Vasculares del VASCERN (VASCA) ha elaborado un informe sobre la vacunación del SARS-CoV-2 en pacientes con malformaciones vasculares. Información

Nos complace presentar una nueva publicación: la revista VASCA. Ella es fruto de la cooperación entre cinco organizaciones de pacientes en Europa, que representan a

Sirolimus has been used in a number of studies as an experimental drug for the treatment of vascular malformations. Especially for patients with lymphatic and

The VASCERN (European Reference Network on Rare Multisystemic Vascular Diseases, specifically the VASCA working group) wrote a statement on Covid-10, initated by patient advocacy groups

All volunteers will meet again online next week Sunday, October 2nd, 20:00h (CET). On the agenda are general plans to find more patients in the

We are proud to announce our first European patient meeting will be in November 11-13 in Leusden, Netherlands. A unique moment for patients in Europe